Skip to content

Clinical trials

Completed Scleroderma, Systemic trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Scleroderma, Systemic Status: Completed Country / region: Canada Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20091
20101
20111
20121
20131
20153
20172
20183
20194
20201
20211
20221
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed24

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Lady Davis Institute9
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's3
Boehringer Ingelheim2
Hoffmann-La Roche2
Actelion1
Alpine Immune Sciences, Inc.1
Bayer1
Genentech, Inc.1
GlaxoSmithKline1
National Institute of Allergy and Infectious Diseases (NIAID)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Scleroderma, Systemic24
Scleroderma, Diffuse15
Skin Diseases2
Ulcer2
Anxiety Disorders1
Autoimmune Diseases1
COVID-191
Colitis, Ulcerative1
Connective Tissue Diseases1
Coronavirus Infections1

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.